Amsterdam Pharmacy Funding: How Much Did They Raise & Key Investors

How Much Did Amsterdam Pharmacy Raise?
Funding & Key Investors

Amsterdam Pharmacy has solidified its position within the pharmaceutical supply chain, securing a significant capital injection to bolster its operational capacity. With a cumulative total of $150K, the firm continues to demonstrate robust financial health. The most recent financing round, which accounted for $150K, underscores the company's commitment to scaling its wholesale distribution network across the Mid-Atlantic and Northeast regions of the United States.

This strategic investment serves as a pivotal milestone for the organization, enabling the firm to enhance its procurement leverage and expand its reach within the global pharmaceutical market. By maintaining a focus on high-volume distribution of Reference Listed Drugs, Amsterdam Pharmacy remains a critical node for clinical research entities and generic manufacturers worldwide.

What is Amsterdam Pharmacy?

Amsterdam Pharmacy

Retail

Drug Stores & Pharmacies

Established in 2003, Amsterdam Pharmacy operates as a sophisticated wholesale pharmacy entity with a footprint spanning New York, New Jersey, Connecticut, Pennsylvania, and Delaware. The company specializes in the procurement and distribution of Reference Listed Drugs and premium brand products. By utilizing its substantial business volume, the firm negotiates favorable pricing structures with manufacturers, passing these efficiencies to a diverse international clientele. Their operational model is built upon authorized distribution and export capabilities, serving partners across India, China, Europe, the Middle East, Canada, and the UK. This global reach, combined with a deep understanding of regulatory compliance and supply chain logistics, positions the company as a leader in the pharmaceutical wholesale sector.

How much funding has Amsterdam Pharmacy raised?

Amsterdam Pharmacy has raised a total of $150K across 1 funding round:

2020

Debt

$150K

Debt (2020): $150K with participation from PPP

Key Investors in Amsterdam Pharmacy

PPP

Public-Private Partnership

What's next for Amsterdam Pharmacy?

Looking ahead, the infusion of capital is expected to accelerate the company's expansion into new international markets and further optimize its logistics infrastructure. As the pharmaceutical industry faces increasing pressure for cost-effective sourcing, Amsterdam Pharmacy is well-positioned to capitalize on its established relationships with global suppliers. The firm's strategic roadmap likely includes the integration of advanced inventory management systems to support its growing export volume. By leveraging its late-stage funding, the company aims to solidify its market dominance, ensuring that it remains the preferred partner for clinical research organizations and generic drug developers seeking reliable, competitively priced pharmaceutical supplies on a global scale.

See full Amsterdam Pharmacy company page

See More Financial Insights